ArticleJournal of imaging2026
Parameter-Efficient LoRA-GRL Adaptation for Cross-Center Classification of Benign and Malignant Lung Nodules on Heterogeneous Standard-Dose Chest CT: A Multi-Institutional Study from Palestine.
Article in Journal of imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Automated CT lung nodule classification suffers from domain shift across centers. We propose LoRA-GRL, combining Low-Rank Adaptation (LoRA) with adversarial domain harmonization via a Gradient Reversal Layer. Rank-8 LoRA modules were inserted into all attention and feed-forward linear projections (48 sites) of a frozen ViT-S backbone; a domain discriminator encouraged center-invariant features across three centers. Normal vs. Benign and Normal vs. Malignant tasks used 264 patients with patient-level five-fold stratified cross-validation. LoRA-GRL achieved AUCs of 0.9735 and 0.9869, close to full fine-tuning (0.9747 and 0.9863). Differences from strongest baselines fell within overlapping 95% CIs under paired bootstrap, indicating comparable discrimination, not superiority. Efficiency is the main advantage: only 0.789 M trainable parameters, a 96.4% reduction from 21.865 M, and inference latency matched full fine-tuning after adapter merging. Grad-CAM showed nodule-localized predictions but also slice-selection failures. For benign classification, higher AUC than plain LoRA came with higher specificity but lower sensitivity. For malignant classification, sensitivity was 0.9412 (5.9 pp above full fine-tuning) and specificity 0.9697. The small cross-center AUC range (0.0011) reflects internal consistency across participating centers, not unseen-site generalization. LoRA-GRL is a promising parameter-efficient candidate for multi-center lung nodule classification, potentially reducing scanner-specific bias and storage/memory needs, but clinical utility requires external validation and prospective evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.